BSEAGM/EGM29 Sept 2026 · 29 Sept 2026, 05:51 pm

Summary of Proceeding of Annual General Meeting

Rekvina Laboratories Ltd · 526075

✦ AI SummaryMgmt Change

Rekvina Laboratories Ltd held its 38th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The meeting approved the audited financial statements for FY 2025-26 and appointed two independent directors, Mr. Prateek Jain and Mr. Jay Chintan Patel.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Rekvina Laboratories Ltd - 526075 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

b5acd78a-179b-41bd-bfc8-dcbc5ccd5e1a.pdf

pdf

Download →
View document text
Summary of the proceedings of the 38th Annual General Meeting of Rekvina Laboratories Limited The 38th Annual General Meeting (‘AGM’) of the Members of Rekvina Laboratories Limited was held on September 29, 2026, at 2.30 P.M. through Video Conferencing in conformity with the regulatory provisions and Circulars issued by the Ministry of Corporate Affairs. Mr. Surbhit Shah welcomed all the Members and dignitaries to the 38th Annual General Meeting of Rakvina Laboratories Limited. Mr. Surbhit Shah informed that the AGM was conducted through Video conferencing in compliance with the circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. Mr. Surbhit Shah confirmed that the quorum was present and declared the meeting in order. Mr. Prateek Jain, Chairman of the meeting addressed the members of the company. Thereafter, the Notice of the AGM, the Statutory Auditors Report on the financial statements and the Secretarial Audit Report were taken as read. Mr. Surbhit Shah instructed the Members on the Ordinary Business and Special Business items covered in the Annual General Meeting Notice dated September 03, 2026 and listed under Serial Nos. 1 to 4 below: Ordinary Business: 1. To consider and adopt the Audited Financial Statement of the Company for the Financial Year ended March 31, 2026 along with the reports of the Board of Directors and Auditors thereon. 2. To appoint a director in place of Mrs. Ilaben Pathak (DIN: 01328714), who retires by rotation and being eligible, offers herself for re-appointment. Special Business: 3. To Appointment of Mr. Prateek Jain (Din: 08611660) as an Independent Director 4. To Appointment of Mr. Jay Chintan Patel (Din: 10147916) as an Independent Director Mr. Surbhit Shah, Director thanked the Members for attending the Annual General Meeting and meeting concluded at 02:45 P.M. Kindly take the same on record. For Rekvina laboratories Limited Surbhit Shah Whole Time Director DIN: 01993300 Date: 29.09.2026 CIN: L24231GJ1988PLC01145 Regd. Office: 3rd floor 5 Laxmi Society, B/h Baroda Heart Institute, O.P. Road, Vadodara – 390007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966